NIKE (NKE)
(Delayed Data from NYSE)
$89.44 USD
+0.05 (0.06%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $89.43 -0.01 (-0.01%) 6:26 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$89.44 USD
+0.05 (0.06%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $89.43 -0.01 (-0.01%) 6:26 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Zacks News
5 Top Shoes & Retail Apparel Industry Stocks to Tap Rising Fitness Trend
by Rajani Lohia
The Shoes and Retail Apparel industry is poised to capitalize on the accelerated digital and exercise-at-home trends. With increased investments in e-commerce and product portfolio, NKE, DECK, SKX, CRI and RCKY have placed themselves well.
3 Sportswear Stocks to Tap on Return of Live Sports to 'Old Normal'
by Vidya Nair
Sportswear companies such as NKE, UAA and SKX are likely to gain from wider audience exposure and promotional opportunities associated with the return of live sports events.
Nike (NKE) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Nike (NKE) delivered earnings and revenue surprises of 23.81% and 6.54%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?
Will Strong Digital Show Bolster NIKE's (NKE) Q2 Earnings?
by Zacks Equity Research
Strong digital sales growth propelled by the shift in consumer preference to online shopping amid the pandemic has been aiding NIKE's (NKE) top line. This is likely to have aided sales in Q2.
Nike (NKE) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Nike (NKE) closed at $136.28 in the latest trading session, marking a -0.82% move from the prior day.
NIKE (NKE) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Robust digital shopping trends across all markets are expected to have aided NIKE's (NKE) top line in Q2. However, soft retail traffic at stores and wholesale revenues are concerning.
Buy Nike Stock Ahead of Earnings Despite LULU's Drop?
by Benjamin Rains
Nike (NKE) is set to release its second quarter fiscal 2021 financial results on Friday, December 18. NKE shares have doubled the market over the last three months...
The Zacks Analyst Blog Highlights: Apple, NIKE, Salesforce, Microsoft and Walmart
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Apple, NIKE, Salesforce, Microsoft and Walmart
Zacks Earnings Trends Highlights: AutoZone, FedEx, NIKE and Oracle
by Zacks Equity Research
Zacks Earnings Trends Highlights: AutoZone, FedEx, NIKE and Oracle
5 Blue-Chip Stocks in Focus With More Than 20% Returns YTD
by Nalak Das
We have narrowed down our search to five Dow stocks that have popped more than 20% year to date. These are AAPL, NKE, CRM, MSFT and WMT.
First Look Ahead to the Q4 Earnings Season
by Sheraz Mian
For 2020 Q4, S&P 500 earnings are expected to be down -11.2% on +0.2% higher revenues, which would follow a -7.8% earnings decline in Q3 on -1% lower revenues...
First Look Ahead to the Q4 Earnings Season
by Sheraz Mian
For 2020 Q4, S&P 500 earnings are expected to be down -11.2% on +0.2% higher revenues, which would follow a -7.8% earnings decline in Q3 on -1% lower revenues...
Nike (NKE) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Nike (NKE) closed at $138.75 in the latest trading session, marking a +1.14% move from the prior day.
Buy Adobe and Lululemon Stock Before Earnings?
by Benjamin Rains
A look at Adobe (ADBE) and Lululemon (LULU) to see if either stock might be worth buying ahead of the release of its upcoming quarterly financial results...
The Zacks Analyst Blog Highlights: Motorola, NIKE and Roper
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Motorola, NIKE and Roper
3 Diverse Stocks That Hiked Dividend Despite Coronavirus Woes
by Supriyo Bose
A handful of stocks has chosen to swim against the coronavirus tide and continued rewarding shareholders with dividend hikes.
Nike (NKE) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Nike (NKE) closed at $134.70, marking a +0.34% move from the previous day.
Dow Tops 30,000: 5 Stocks Driving the ETF
by Sweta Killa
The Dow Jones topped the 30,000 milestone for the first time on vaccine optimism, and improving prospects for the smooth transition of President-elect Joe Biden to White House.
Nike (NKE) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Nike (NKE) closed the most recent trading day at $134.70, moving +0.42% from the previous trading session.
Nike (NKE) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Nike (NKE) closed at $130.11, marking a +1.43% move from the previous day.
3 Strong Stocks to Buy for the Second Half of Q4 and Beyond
by Benjamin Rains
We explore three highly-ranked large-cap stocks that are poised to grow and don't necessarily need a vaccine boost...
The Zacks Analyst Blog Highlights: Nike, Dow, Procter & Gamble Company, 3M and Microsoft
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nike, Dow, Procter & Gamble Company, 3M and Microsoft
Buy Surging Yeti Stock for Lululemon-Style Growth Potential?
by Benjamin Rains
High-end cooler company Yeti topped our third quarter estimates last week and its growth potential appears strong...
5 Blue-Chip Stocks to Buy on Coronavirus Vaccine Hope
by Nalak Das
A COVID-19 vaccine likely to benefit the Dow the most as it is more inclined toward cyclical stocks. Five among these are NIKE (NKE), Dow (DOW), The Procter & Gamble (PG), 3M (MMM) and Microsoft (MSFT).
Nike (NKE) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Nike (NKE) closed at $128.95 in the latest trading session, marking a +0.04% move from the prior day.